Hemostemix Inc.
HMTXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9,898 | $5,412 | $12,319 | $8,784 |
| - Cash | $706 | $155 | $136 | $219 |
| + Debt | $4,937 | $4,322 | $4,126 | $1,482 |
| Enterprise Value | $14,129 | $9,578 | $16,309 | $10,047 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$1,979 | -$2,333 | -$3,273 | -$2,768 |
| % Margin | – | – | – | – |
| Net Income | -$2,616 | -$2,502 | -$5,235 | -$6,286 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.028 | -0.03 | -0.075 | -0.11 |
| % Growth | 9.2% | 59.5% | 32% | – |
| Operating Cash Flow | -$1,902 | -$1,420 | -$6,102 | -$3,478 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1,902 | -$1,420 | -$6,102 | -$3,478 |